Launch Fragility Index
Where your launch assumptions are most at risk—and what's safe to scale.
The belief that adoption is automatic. It's not.
In healthcare, the best product doesn't win.
The products that win are the ones that change lives AND minds.
The Pivotal Commercial Design Review (PCDR) is your Launch Insurance—how you stress-test belief before you scale.
You Validate the Science.
Now Validate Market Readiness.
Every company believes they're ready for launch—until the market proves otherwise.
Clinical data, funding, and TAM slides don't guarantee adoption. They create confidence. But internal confidence isn't market belief. The market won't move until it believes.
That's where the PCDR comes in. It's belief engineering—the proven due diligence for commercial success.
Validate market readiness and you don't just launch a product.
You launch a category.
of the market valuation is captured by category leaders
Over three weeks, we'll uncover the belief gaps standing between your product and market adoption.
Internal assumptions that create false confidence
The market's belief gaps that threaten adoption
The truth about launch readiness before millions get spent scaling the wrong story
You'll walk away with the three artifacts every board should demand before launch:
Where your launch assumptions are most at risk—and what's safe to scale.
A new lens to see the gap between product readiness and market readiness.
The go/no-go clarity boards and investors demand before millions are spent.
Find out where your launch is at risk.
Get commercial launch insurance.